Editorial: How underappreciated autoinflammatory mechanisms (innate immunity) dominate disparate autoimmune disorders

作者
Qiao Zhou,Yue Yang,Dennis McGonagle
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:16: 1762297-1762297
标识
DOI:10.3389/fimmu.2025.1762297
摘要

The aim of this Research Topic was to investigate how innate immune pathways-often relegated to the periphery of "classical autoimmunity" -in fact organize, initiate, or amplify inflammation across a range of conditions historically classified as autoimmune. The contributions gathered here collectively propose a spectrum-based perspective. This view blurs rigid boundaries between autoimmunity and autoinflammation, highlights neutrophil-and barrier-centric mechanisms, and suggests therapeutic strategies that either target upstream innate triggers or modulate adaptive immunity with an awareness of innate mechanisms. Together, they call for an integrated immune paradigm, one that better reflects the biology of human disease and offers more actionable insights for clinical practice.At the conceptual core, Abacar et al. revisit the intellectual history from horror autotoxicus to "horror autoinflammaticus", and then deliberately stitch these concepts back together into a unified continuum (1). They show how diseases long considered archetypes of adaptive autoimmunity (e.g., RA and SLE) frequently rely on innate events for their initiation. It also details how barrier failure and dysbiosis drive adaptive immune cascades in mucosal disorders. Their review further profiles the disease landscape from MHC-II-associated disorders to MHC-I-opathies and the bridging roles of unconventional lymphocytes. The argument is made that numerous "autoimmune" phenotypes are more accurately understood as composite, multi-stage processes where innate and adaptive immunity act sequentially or in concert.Two original studies then ground this integrative view in empirical data. In rheumatoid arthritis, Li et al. dissect the synovial microenvironment and elevate neutrophils -often overlooked in the discussions of RA pathogenesis-at a center role (2). Using single-cell and bulk transcriptomic integration with machine-learning prioritization, they identify seven major cellular compartments, with neutrophils being the most abundant. They map extensive crosstalk between neutrophils and fibroblasts (including MIF, collagen, and Fn1 signaling) and develop a clinically relevant, four-gene diagnostic model related to NETs (CRYBG1, RRM2, MMP1, SLC19A2). Their work reframes RA as an ecosystem where neutrophil extracellular traps (NETs) contribute to fibroblast pathogenicity and shape T-cell antigen presentation, supporting the idea that "autoimmune RA" is nevertheless scaffolded by neutrophil-driven innate events.Those RA insights resonate with the continuum articulated by Abacar et al., who describe how citrullination and PAD-driven antigen editingprocesses classically invoked to explain ACPA-positive adaptive autoimmunity-are themselves initiated by innate signals such as macrophage activation, Ca²⁺ flux, and NETosis. This sequence-innate ignition, adaptive specification, innate effector return-helps explain why therapies targeting both sides of immunity can be effective in the same patient and even at different disease stages.On the mucosal end of the spectrum, Abacar et al. also emphasize how barrier disruption, PRR sensing, and innate gene variants (e.g., NOD2, CARD9) establish a foundation for the IL-23/Th17 axis and subsequent adaptive immune circuitry in IBD. This again illustrates disease trajectories that start as autoinflammation and progressively acquire adaptive hallmarks.The therapeutic implications of an integrated view are brought into focus by Liu et al., who apply a Bayesian network meta-regression to biologics in lupus nephritis and, crucially, adjust for follow-up duration(3). They confirm that several agents-particularly obinutuzumab-can achive faster remission early on. This reveals a clinically meaningful "time-window" of advantage versus standard therapy alone. As follow-up extends, these relative differences attenuate, underscoring standard care as a durable base while clarifying when targeted biologics provide the most added value. Despite the multifaceted involvement of innate immunity in SLE, B-cell depletion and thus suppression of central adaptive immunity responses thus remains central to SLE therapeutics. This time-sensitive perspective argues for treatment strategies tailored to disease stage, acknowledging the shifting balance between innate and adaptive immune dominance across the course of LN.Finally, Chen et al. review mesenchymal stem cells (MSCs) as potential immunologic "equalizers", capable of fine-tuning both innate and adaptive immunity via direct contact and paracrine programs, including EVs(4). Mechanistically, the review details how MSCs can promote regulatory T-cell circuits (e.g., via PD-L1/PD-1) and reprogram innate effector cells (e.g., macrophages, dendritic cells, NK cells). This positions MSC-based therapy as a platform capable of dampening hyperreactive immune loops, irrespective of whether they originate from innate or adaptive triggers. In conditions across the autoinflammatory-autoimmune spectrum, such dual modulation could be particularly attractive when the initial trigger is innate but the clinical phenotype has matured into mixed, relapsing immunopathology.Three practical messages emerge. First, timing is critical. Innate immune circuits can dominate early phases and be most amenable to intervetion then (e.g., the early advantage of biologics in LN), while adaptive immune plateaus may govern long-term maintenanceadvocating for adaptive trial designs and dynamic treatment algorithms aligned with disease phase. Second, neutrophils are key players. Across different tissues, NETs and neutrophil-stromal interactions appear capable of initiating site-specific pathology and antigen presentation. This makes neutrophil biology a rich source for novel biomarkers and therapeutic targets (e.g., diagnostic models, NET-directed strategies, MIF pathway inhibition). Third, bridging therapies hold promise. Therapeutic platforms like MSCs, and, more broadly, strategies that temper inappropriate innate activation while preserving essential host defense, may complement antigen-specific or B/T-cell-directed agents, especially in diseases with mixed-phenotype.In summary, this Research Topic reframes disparate autoimmune diagnoses as variations on a shared choreography in which innate immunity is not merely the opening act but often the choreographerpriming tissues, instructing stromal partners, and shaping the subsequent adaptive repertoire. The articles collected here delineate key mechanistic threads (NETs, PAD activation, PRR checkpoints, IL-23 axis, neutrophil-fibroblast signaling) and provide methodological and therapeutic frameworks (time-aware evidence synthesis; MSC-based modulation; biomarker-guided models) to translate this refined understanding into clinical practice. We anticipate that future work combining longitudinal immune phenotyping with precise interventional timing, and pairing innate-targeted agents with adaptive immune controllers, will lead to more durable disease control with fewer trade-offs-a direction firmly rooted in the integrative biology emphasized throughout these contributions.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fancy完成签到,获得积分10
刚刚
小猫挠屁股完成签到 ,获得积分10
1秒前
1秒前
真实的百川完成签到,获得积分10
1秒前
元吉的应助被zx采纳,获得10
2秒前
领导范儿的应助被寻找布冯采纳,获得10
3秒前
haaaaa完成签到 ,获得积分10
5秒前
5秒前
5秒前
瑾钰满糖完成签到,获得积分10
6秒前
Peter发布了新的文献求助10
6秒前
6秒前
科研通AI6.4的应助被Gg采纳,获得10
7秒前
7秒前
科研通AI6.2的应助被林川采纳,获得30
8秒前
8秒前
WilliamTT发布了新的文献求助10
9秒前
明天完成签到,获得积分10
9秒前
10秒前
molihuakai的应助被激昂的如柏采纳,获得10
12秒前
12秒前
回望发布了新的文献求助10
12秒前
12秒前
yawngale发布了新的文献求助10
12秒前
旧城以西发布了新的文献求助10
13秒前
hhud完成签到 ,获得积分10
13秒前
13秒前
顾矜的应助被Arthur采纳,获得10
14秒前
华仔的应助被洁净的千凡采纳,获得10
14秒前
脑洞疼的应助被喵喵机采纳,获得10
15秒前
km发布了新的文献求助10
15秒前
samzix完成签到,获得积分10
15秒前
orrange完成签到,获得积分10
15秒前
CodeCraft的应助被寻找布冯采纳,获得10
16秒前
大个的应助被Chris采纳,获得10
16秒前
纯纯么么哒完成签到 ,获得积分10
16秒前
zengfan发布了新的文献求助10
16秒前
3213123完成签到,获得积分10
17秒前
一饮一啄完成签到,获得积分10
17秒前
lin888完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177802
求助须知:如何正确求助?哪些是违规求助? 9568632
关于积分的说明 21799933
捐赠科研通 7772424
什么是DOI,文献DOI怎么找? 3432505
关于科研通互助平台的介绍 2556698
邀请新用户注册赠送积分活动 2478055